Patients with acute liver failure (ALF) or acute-on-chronic liver failure (ACLF) are at high risk of bleeding with ...

There is an apparent underuse of warfarin in elderly patients with AF, as there is inconsistency in opinion among clinicians about who should receive anticoagulation. The risks of warfarin are ...

Background and objectives Patients with acute liver failure (ALF) or acute-on-chronic liver failure (ACLF) are at high risk ...

The CHEST guidelines currently recommend a minimum of 3 months of anticoagulation, emphasizing that after this period, patients should be reassessed to determine whether continuing therapy is ...

Patients with acute liver failure (ALF) or acute-on-chronic liver failure (ACLF) are at high risk of bleeding with traditional artificial liver ...

Chronic fatigue syndrome isn't just being tired. It's a new state of fatigue that has lasted for at least 6 months. CFS is more than feeling tired all the time. It comes with a lot of other ...

CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Gearing Up for Phase 3 Trial of Tecarfarin Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) is a biopharmaceutical company developing tecarfarin, a ...

Emergen Research Logo The advancements in medical technology the increasing prevalence of chronic conditions like cardiovascular diseases o ...